Share Print

Funding Opportunities in Cancer Research

 

research1  

For assistance with funding, contact: 
Paige Isom, Research Adminstrator,
Funding and Awards
Phone: 314-454-8980
E-mail:  isomp@wudosis.wustl.edu

 

 

FUNDING OPPORTUNITY SEARCH TOOLS 

Siteman Cancer Center — Internal

Barnes-Jewish Foundation
  

Deadline Funding Opportunity Sponsor Amount Description
Feb. 12, 2015 Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) NCI  Up to $100,000 toward salary and $30,000 toward research development per year for 5 years The NCI-sponsored K08 award is specifically designed to promote career development of clinical scientists from diverse backgrounds that have been shown to be underrepresented in health-related science and for those who are committed to a career in basic biomedical, behavioral or translational cancer research, including research on cancer health disparities.
Feb. 12, 2015 Transition Career Development Award (K22) NCI  Up to $100,000 toward salary and $50,000 toward research development per year for 3 years This FOA represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions.
Internal Competiton: Feb. 16, 2015 NEW: DeNardo Education and Research Foundation Grant Program DeNardo Eductaion and Research Foundation $50,000 over a two-year period The purpose of the DeNardo Education and Research Foundation is to support education and research in the health sciences, broadly defined, with preference for activities that relate to the field of medicine. Programs of greatest interest to the Foundation include: health science lectureships, programs to decrease institutional bureaucracies, student research scholarships, and preclinical cancer research relating to novel therapy and imaging. 
Feb. 27, 2015 and June 29, 2015 NEW: NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) NCI $275,000 The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research.
March 6, 2015 Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis (R01) NCI  Application budgets are not limited but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum period is 5 years. This FOA encourages applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem.
March 17, 2015 NEW: Innovative Technologies for Cancer-Relevant Biospecimen Science (R21) NCI $400,000 over three years (no more than $200,000 in a single year) This FOA solicits grant applications proposing exploratory research projects on the inception and early-stage development of technologies that address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and storage of cancer-relevant biospecimens.
March 17, 2015 NEW: Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33) NCI $300,000 per year; up to three years  This FOA solicits grant applications proposing research projects on the advanced development and validation of technologies that address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and storage of cancer-relevant biospecimens.
March 17, 2015 NEW: Innovative Molecular Analysis Technologies for Cancer Research (R21) NCI $400,000 over three years (no more than $200,000 in a single year) This FOA solicits grant applications proposing exploratory research projects focused on the inception and development of early-stage, highly innovative, molecular and/or cellular analysis technologies with transformative potential not yet explored in cancer-relevant use.
March 17, 2015 NEW: Advanced Development and Validation of Emerging Molecular Analysis Technologies for Cancer Research (R33) NCI $300,000 per year; up to three years This FOA solicits grant applications proposing research projects on the advanced development of emerging molecular and cellular analysis technologies and validation in an appropriate cancer-relevant biological system.
May 21, 2015 NEW: Interpreting Variation in Human Non-Coding Genomic Regions Using Computational Approaches and Experimental Assessment (R01) NIH/NHGRI/NCI/NIDA Up to $500,000 per year for three years This FOA solicits applications to develop highly innovative computational approaches for interpreting sequence variants in the non-protein-coding regions of the human genome. NCI solicits applications for studies focusing on germline variants related to cancer susceptibility.
June 17, 2015 NEW: Basic Cancer Research in Cancer Health Disparities (R01, R21) NCI Up to $250,000 per year for five years This R01 FOA encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. This FOA has a companion funding opportunity (R21).